Schizophrenia Clinical Trials in Los Angeles

Showing 181-200 of 204 trials

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

NCT00085891

The purpose of this study is to demonstrate superior efficacy of sustained release quetiapine compared to placebo in patients with schizophrenia after receiving treatment for up to 6 weeks.

Schizophrenia

AstraZeneca535 participantsStarted Jun 2004

Birmingham, Alabama, United States • Cerritos, California, United States • Los Angeles, California, United States +26 more locations

COMPLETEDPhase 2< 1 mile

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

NCT00528905

The purpose of this study is to demonstrate that AZD3480 improves cognition in patients with stable schizophrenia who are being treated with an atypical antipsychotic and who are active cigarette smokers, to assess the safety and tolerability of AZD3480 and to define the optimal dose(s) to be used in future trials.

Schizophrenia

AstraZeneca400 participantsStarted Aug 2007

Little Rock, Arkansas, United States • Anaheim, California, United States • Cerritos, California, United States +77 more locations

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Schizophrenia Trials in Other Cities

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Digoxin Drug-Drug Interaction With Lurasidone HCl

Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Promoting Adherence to Treatment in Schizophrenia

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Other Conditions in Los Angeles